undamentalytics Newsletter
Sign in

American Vanguard Corp (AVD) stock

Add to watchlist

Add holding +

NYSE: AVD NYSE Fertilizers & Agricultural Chemicals Next results ~November 9, 2026

D Fundamentals grade

American Vanguard Corp is a US-listed company in the fertilizers & agricultural chemicals industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Model estimate per share

~$2.0

Revenue-to-maturity cash-flow model

Base case. Range ~$2.0–$5.2 across our lower- and higher-growth cases (0%–5% a year).

Price vs value

No Buy/Hold/Sell rating is issued: only 1 valuation models apply; a rating needs 3.

American Vanguard Corp valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders3 buying, 1 selling5 purchases and 1 sale by directors and officers, last 12 monthsInsider trades
  • Funds56 adding, 67 cuttingOf 28 active managers that changed their stake, 17 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter American Vanguard files

10-Q filed August 10: American Vanguard

American Vanguard's trailing twelve-month revenue to June 2026 fell 3.5% to $510m, a sharper decline than the 1.0% drop recorded a quarter earlier. Free-cash-flow margin deteriorated to -9.2% from 1.9% a year earlier, even as operating margin widened to -5.2% from -18.6%. Against this backdrop, our revenue-to-maturity cash-flow model puts fair value at $6.40 a share, well above the current share price of $1.10.

Source: 10-Q filed August 10, 2026 on SEC EDGAR · Financials · Valuation

Earlier notes (1)

Where American Vanguard stands after its latest 10-K/A

Revenue for the twelve months to December 2025 was $510m, down 3.5% on a year earlier, a steeper fall than the 1.0% decline a quarter earlier. Free-cash-flow margin fell to -9.2% from 1.9% a year earlier. Operating margin widened to -5.2% from -18.6%. Against its peers on growth, profitability, cash generation and balance sheet, it grades D. It passes 2 of our 6 financial-health checks.

10-K/A on SEC EDGAR

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~November 9, 2026 (estimated)

American Vanguard Corp's trailing-twelve-month revenue fell 3.5% year on year, with a free-cash-flow margin of -9.2%. Where it lags: days sales outstanding of 125 days ranks 7 of 7 fertilizers & agricultural chemicals companies we cover.

Current signal Gross margin expanding: TTM gross margin reached 29.4%, up 8.4pp year over year.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Margins widening. Operating margin is up 13.3 points on a year ago.

Things to watch

  • Revenue shrinking. Revenue fell 3.5% over the last 12 months.
  • Loss-making. Operating margin is -5.2%: costs exceed revenue.
  • Burning cash. Free cash flow was -9.2% of revenue over the last 12 months.
  • Volatile shares. Over the past year the shares showed annualised volatility of 71% and a beta of 1.2 against the S&P 500.
  • Growth easing. The growth rate is 2.6 points lower than a quarter earlier.
  • Below peers: days sales outstanding. Days sales outstanding of 125 days ranks 7 of 7 fertilizers & agricultural chemicals companies we cover (median 75 days).

Latest results: FY2026 Q2

Filed August 10, 2026
Revenue
$117m, down 9.7% on a year earlier
Share reaction
-5.2% in the first session after the results on August 11, 2026, against -0.1% for the S&P 500
Guidance given
sales $530m to $550m (Full-Year); adjusted EBITDA $44m to $48m (Full-Year)
Next report
November 9, 2026

American Vanguard's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day-0.9%
  • 1 week+1.9%
  • 1 month-37.4%
  • This year-71.5%
  • 1 year-75.6%
  • 5 years-93.1%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$510M
Operating margin
-5.2%
Net margin
-10.7%
EPS (TTM, diluted)
$-1.91

Growth

Revenue growth
−3.5%
Change in growth rate
−2.6 pts
Share count change
+1.5%

Cash

Free cash flow (TTM)
-$47M
FCF margin
-9.2%
Stock pay % of revenue
0.3%

Earnings

Last results
August 11, 2026
Next results (est.)
November 18, 2026

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Leadership
  2. Insider trade
  3. Results
  4. Guidance

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

American Vanguard Corp valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: only 1 valuation models apply; a rating needs 3.

Valuation models

We value American Vanguard Corp as an operating company, with every model that fits that kind of business. Cost of equity 7.7%: the 10-year Treasury yield (4.9%) plus a beta of 0.62 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Revenue-to-maturity model Revenue grown to maturity with the cash margin moving to the industry's; for companies not yet profitable. ~$2.0 ~$2.0–$5.2 Primary model, counts double
Price-to-earnings vs peers Earnings per share times peers' typical (harmonic-mean) price-to-earnings. — Does not apply: no positive earnings in the latest twelve months
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. — Does not apply: the model gives no positive value
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. — Does not apply: return on equity is not positive
Price-to-sales vs peers Sales per share times peers' typical price-to-sales; used only when earnings are negative. ~$6.0 ~$8.2–$22 Left out: out of range vs price (5.52x)
Combined value Weighted average of the models that apply: the primary model (revenue-to-maturity model) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$2.0 ~$2.0–$5.2 1 model

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare American Vanguard Corp with Fertilizers & Agricultural Chemicals in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Valuation multiples over time Market data may be delayed

At fiscal year end 20152016201720182019202020212022202320242025Now
Share price$13.44$18.41$18.95$14.71$18.95$15.15$16.08$21.40$10.91$4.63$3.82$1.09
Market value$393m$541m$563m$442m$562m$454m$489m$639m$311m$130m$109m$31m
+ Net debt (− = net cash)$64m$34m$66m$91m$142m$92m$36m$31m$0$0$0$0
Enterprise value$457m$575m$629m$533m$704m$546m$525m$671m$311m$130m$109m$31m
Multiples
Price / sales 1.4x1.7x1.6x1.0x1.2x1.0x0.9x1.0x0.5x0.2x0.2x0.1x
Price / earnings 59.6x42.3x27.8x18.3x41.3x29.8x26.3x23.3x41.4x———
Price / free cash flow 5.5x15.1x10.8x122.5x—5.7x6.4x14.6x————
EV / EBITDA 16.3x15.6x14.4x9.2x15.7x12.8x13.1x13.5x10.4x———

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

34 /100

Weak moat

How hard American Vanguard's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 0 / 20

    Net income has been a median 2.1% of total assets over 10 years.

  • Pricing power 8 / 20

    Gross margin has been a median 34.0%, moving by 6.4 percentage points (standard deviation) across 10 years.

  • Durability 0 / 20

    Operating margin has been a median 5.0%; its worst year was -18.6%.

  • Cash conversion 8 / 20

    Free cash flow was positive in 6 of 10 years, at a median 3.7% of revenue.

  • Discipline 19 / 20

    The diluted share count fell 5.6% over five years; stock-based pay has been a median 1.2% of revenue.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: November 9, 2026, after the close.

Analysts' consensus

No analyst estimates are published for American Vanguard Corp: too few analysts cover it.

Management guidance

Earnings release, August 11, 2026
  • Sales Full-Year $530m to $550m Maintained
    “Reaffirm Full-Year Outlook; Adjusted EBITDA $44 million to $48 million on Sales of $530 million to $550 million” source
  • Adjusted EBITDA Full-Year $44m to $48m Non-GAAP Maintained
    “Reaffirm Full-Year Outlook; Adjusted EBITDA $44 million to $48 million on Sales of $530 million to $550 million” source

Figures and quotations are management's, copied from the company's own press release (SEC 8-K exhibit) and checked word for word against it. Forward-looking statements are the company's expectations, not ours and not advice; guidance can change or be missed.

Positioning

Short interest
1.1%
of tradable shares
Days to cover
0.63
at average volume
Short interest, 1 month
+56%
to October 15, 2026
Held by institutions
56%
of shares
Held by insiders
6.7%
of shares
Employees
739
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months −75.6%

$4.47 on October 31, 2025 to $1.09

ThenNowEffect
Revenue (last 12 months) $529m $510m −3.5%
P/S multiple 0.2x 0.1x −74.3%
Share count 28m 29m −1.5%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

Last 3 years −88.8%

$9.76 on November 3, 2023 to $1.09

ThenNowEffect
Revenue (last 12 months) $569m $510m −10.4%
P/S multiple 0.5x 0.1x −87.7%
Share count 29m 29m +1.8%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
AVD+6%+33%−49%−58%−18%−72%
Industry peers (median)+72%+16%−16%+8%+1%+15%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
AVD42%42%50%25%42%27%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
AVD−36%−29%−63%−67%−46%−81%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since November 2, 2015: 96% from June 2, 2022 to October 23, 2026. Getting back needed a 2368% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$1.03 – $5.41
From 52-week high
−79.9%
vs 50-day average
−37.8%
vs 200-day average
−61.8%
Volatility (1 year)
71%
Beta vs S&P 500
1.17

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
4 up, 8 down
typical move ±12.8%
After a week
2 up, 10 down
typical move ±14.8%
After a month
2 up, 10 down
typical move ±18.0%
Results releasedNext dayS&P 500 next day5 days21 days
August 11, 2026 −5.2% −0.1% −5.2% −2.6%
March 18, 2026 −25.4% −1.6% −37.7% −24.6%
November 12, 2025 +4.5% −1.6% −9.4% −11.3%
August 1, 2025 +12.7% −0.1% +20.5% +39.9%
June 6, 2025 −8.2% +1.1% −13.8% −13.8%
March 14, 2025 +0.6% +2.9% −3.4% −18.5%
November 12, 2024 +13.6% −0.3% +12.2% −6.9%
August 9, 2024 −31.6% +0.5% −30.4% −26.1%
May 10, 2024 −26.7% +0.1% −28.0% −30.2%
March 18, 2024 −5.1% +1.2% −2.2% −12.4%
November 9, 2023 −5.4% +0.8% −2.9% +5.9%
August 9, 2023 −14.7% −0.6% −11.7% −23.3%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

American Vanguard Corp in five measures

Fundamentals grade D
Growth Profitability Cash Balance sheet

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) American Vanguard Corp
$500M $520M $540M $560M $580M $600M FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue (TTM), FY23 Q3: $566.7M Revenue (TTM), FY23 Q4: $579.4M Revenue (TTM), FY24 Q1: $589.6M Revenue (TTM), FY24 Q2: $585M Revenue (TTM), FY24 Q3: $553.8M Revenue (TTM), FY24 Q4: $547.3M Revenue (TTM), FY25 Q1: $528M Revenue (TTM), FY25 Q2: $529.1M Revenue (TTM), FY25 Q3: $530.1M Revenue (TTM), FY25 Q4: $515.1M Revenue (TTM), FY26 Q1: $522.9M Revenue (TTM), FY26 Q2: $510.3M $510.3M

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue (TTM)
FY23 Q3 $566.7M
FY23 Q4 $579.4M
FY24 Q1 $589.6M
FY24 Q2 $585M
FY24 Q3 $553.8M
FY24 Q4 $547.3M
FY25 Q1 $528M
FY25 Q2 $529.1M
FY25 Q3 $530.1M
FY25 Q4 $515.1M
FY26 Q1 $522.9M
FY26 Q2 $510.3M
Revenue growth, TTM YoY American Vanguard Corp
-15% -10% -5% 0% 5% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue growth, TTM YoY, FY23 Q3: -7.0% Revenue growth, TTM YoY, FY23 Q4: -5.0% Revenue growth, TTM YoY, FY24 Q1: 0.8% Revenue growth, TTM YoY, FY24 Q2: 2.7% Revenue growth, TTM YoY, FY24 Q3: -2.3% Revenue growth, TTM YoY, FY24 Q4: -5.5% Revenue growth, TTM YoY, FY25 Q1: -10.5% Revenue growth, TTM YoY, FY25 Q2: -9.6% Revenue growth, TTM YoY, FY25 Q3: -4.3% Revenue growth, TTM YoY, FY25 Q4: -5.9% Revenue growth, TTM YoY, FY26 Q1: -1.0% Revenue growth, TTM YoY, FY26 Q2: -3.5% -3.5%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q3 -7.0%
FY23 Q4 -5.0%
FY24 Q1 0.8%
FY24 Q2 2.7%
FY24 Q3 -2.3%
FY24 Q4 -5.5%
FY25 Q1 -10.5%
FY25 Q2 -9.6%
FY25 Q3 -4.3%
FY25 Q4 -5.9%
FY26 Q1 -1.0%
FY26 Q2 -3.5%
Operating margin (TTM) American Vanguard Corp
-30% -20% -10% 0% 10% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Operating margin (TTM), FY23 Q3: 2.7% Operating margin (TTM), FY23 Q4: 4.0% Operating margin (TTM), FY24 Q1: 4.4% Operating margin (TTM), FY24 Q2: 2.2% Operating margin (TTM), FY24 Q3: -3.5% Operating margin (TTM), FY24 Q4: -18.6% Operating margin (TTM), FY25 Q1: -21.2% Operating margin (TTM), FY25 Q2: -18.6% Operating margin (TTM), FY25 Q3: -14.4% Operating margin (TTM), FY25 Q4: -5.5% Operating margin (TTM), FY26 Q1: -4.2% Operating margin (TTM), FY26 Q2: -5.2% -5.2%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Operating margin (TTM)
FY23 Q3 2.7%
FY23 Q4 4.0%
FY24 Q1 4.4%
FY24 Q2 2.2%
FY24 Q3 -3.5%
FY24 Q4 -18.6%
FY25 Q1 -21.2%
FY25 Q2 -18.6%
FY25 Q3 -14.4%
FY25 Q4 -5.5%
FY26 Q1 -4.2%
FY26 Q2 -5.2%
FCF margin (TTM) American Vanguard Corp
-20% -10% 0% 10% 20% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 FCF margin (TTM), FY23 Q3: -9.9% FCF margin (TTM), FY23 Q4: -12.2% FCF margin (TTM), FY24 Q1: -11.2% FCF margin (TTM), FY24 Q2: -3.7% FCF margin (TTM), FY24 Q3: 10.2% FCF margin (TTM), FY24 Q4: -0.6% FCF margin (TTM), FY25 Q1: 2.9% FCF margin (TTM), FY25 Q2: 1.9% FCF margin (TTM), FY25 Q3: -1.0% FCF margin (TTM), FY25 Q4: -4.9% FCF margin (TTM), FY26 Q1: -7.7% FCF margin (TTM), FY26 Q2: -9.2% -9.2%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q3 -9.9%
FY23 Q4 -12.2%
FY24 Q1 -11.2%
FY24 Q2 -3.7%
FY24 Q3 10.2%
FY24 Q4 -0.6%
FY25 Q1 2.9%
FY25 Q2 1.9%
FY25 Q3 -1.0%
FY25 Q4 -4.9%
FY26 Q1 -7.7%
FY26 Q2 -9.2%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-K/A, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2009 Dec 2009 2010 Dec 2010 2011 Dec 2011 2012 Dec 2012 2013 Dec 2013 2014 Dec 2014 2015 Dec 2015 2016 Dec 2016 2017 Dec 2017 2018 Dec 2018 2019 Dec 2019 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Jun 2026
Income
Revenue 206 227 301 366 381 299 289 312 355 454 468 459 558 610 579 547 515 510
Gross profit 57 86 123 161 171 114 112 128 147 183 177 173 171 192 179 120 148 150
EBITDA 4 30 53 73 71 23 28 37 44 58 45 43 40 50 30 −96 −23 −28
Operating income −6 19 39 59 56 7 12 21 27 39 26 23 31 41 23 −102 −28 −27
Net income −6 11 22 37 34 5 7 13 20 24 14 15 19 27 8 −126 −50 −55
Diluted EPS −$0.21 $0.40 $0.79 $1.28 $1.19 $0.17 $0.23 $0.44 $0.68 $0.81 $0.46 $0.51 $0.61 $0.92 $0.26 −$4.50 −$1.75 −$1.91
Growth (year on year)
Revenue — +10.2% +32.7% +21.6% +4.1% −21.6% −3.1% +7.9% +13.8% +27.9% +3.1% −2.0% +21.6% +9.3% −5.0% −5.5% −5.9% −3.5%
EBITDA — +577.4% +74.1% +38.0% −3.1% −67.4% +21.5% +31.7% +18.7% +32.4% −22.5% −4.6% −6.1% +23.3% −39.7% −422.5% — —
Operating income — — +104.4% +51.2% −6.0% −88.0% +71.7% +78.2% +30.4% +45.6% −32.8% −12.6% +35.1% +31.4% −42.7% −536.0% — —
Net income — — +100.9% +67.1% −6.6% −85.9% — +94.0% +58.5% +19.3% −43.8% +12.1% +21.9% +47.4% −72.6% — — —
Diluted EPS — — +97.5% +62.0% −7.0% −85.7% — +91.3% +54.5% +19.1% −43.2% +10.9% +19.6% +50.8% −71.7% — — —
Margins
Gross margin 27.6% 38.1% 40.9% 44.0% 45.0% 38.3% 38.7% 41.1% 41.5% 40.2% 37.9% 37.6% 30.6% 31.6% 30.9% 22.0% 28.6% 29.4%
EBITDA margin 2.2% 13.4% 17.5% 19.9% 18.5% 7.7% 9.7% 11.8% 12.3% 12.7% 9.6% 9.3% 7.2% 8.1% 5.2% −17.6% −4.5% −5.4%
Operating margin −3.1% 8.5% 13.0% 16.2% 14.6% 2.2% 4.0% 6.6% 7.5% 8.6% 5.6% 5.0% 5.5% 6.7% 4.0% −18.6% −5.5% −5.2%
Net margin −2.8% 4.8% 7.3% 10.1% 9.0% 1.6% 2.3% 4.1% 5.7% 5.3% 2.9% 3.3% 3.3% 4.5% 1.3% −23.1% −9.7% −10.7%
Free-cash-flow margin 13.4% 11.1% 11.0% 6.2% −5.6% −13.8% 24.8% 11.5% 14.7% 0.8% −0.7% 17.2% 13.8% 7.2% −12.2% −0.6% −4.9% −9.2%
Cash flow
Cash from operations 32 33 39 40 −6 −34 79 46 59 12 10 90 86 57 −59 4 −21 −42
Capital spending 4 8 6 18 15 7 7 11 7 8 13 11 10 13 12 7 4 5
Free cash flow 28 25 33 23 −21 −41 72 36 52 4 −3 79 77 44 −71 −3 −25 −47
Stock-based pay 1 1 2 3 4 4 4 3 5 6 7 7 7 6 6 4 2 2
Free cash flow after stock pay 26 24 31 20 −25 −45 68 33 48 −2 −11 73 70 38 −77 −8 −27 −49
Balance sheet
Cash 0 1 35 38 7 5 6 8 11 6 7 16 16 20 — — — —
Total debt 0 8 81 52 52 100 69 41 77 97 149 107 52 51 139 147 174 268
Net debt (negative = net cash) −0 7 46 14 45 95 64 34 66 91 142 92 36 31 — — — —
Diluted shares 27m 28m 28m 29m 29m 29m 29m 29m 30m 30m 30m 30m 30m 30m 29m 28m 28m 29m
Returned to shareholders
Dividends 2 1 2 6 5 6 1 1 2 2 2 1 2 3 3 3 0 —
Buybacks — — — — 2 2 — — — 7 3 0 5 34 16 0 0 —
Total returned 2 1 2 6 7 7 1 1 2 9 5 1 7 37 19 3 0 —

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

2 of 6 checks passed · June 30, 2026
What it owns · $635m
Short-term assets $418mLonger-term assets $218m
What it owes, and who funded it · $635m
Short-term liabilities $169mLonger-term liabilities $285mShareholders' equity $181m
  • Short-term assets cover short-term liabilities $418m of assets due within a year against $169m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $418m short-term assets against $285m of longer-dated liabilities.
  • More cash than debt Cash or debt not separately reported. Not assessable.
  • Debt below 40% of shareholders' equity Debt is 148% of equity.
  • Debt burden no higher than five years ago Debt to equity moved from 14% to 148% over five years.
  • A year's operating cash flow covers at least 20% of debt −$42m of operating cash flow against $268m of debt.
  • Operating profit covers interest at least five times over Operating income of −$27m against $25m of interest.

From American Vanguard Corp's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

Dividends (TTM)
$0
Buybacks, last 3 fiscal years
$15.5M
Diluted share count
+1.5%
year over year
Total shareholder yield
0.0%
dividends 0.0% + buybacks 0.0% of market value
R&D spending
4.6%
of revenue
Sales & admin spending
21.5%
of revenue
Days sales outstanding
125 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in fertilizers & agricultural chemicals
Last 12 months unless stated AVD UAN BIOX FMC SMG ICL Median
Revenue, last 12 months $510m $677m $238m $2.8bn $3.5bn $7.2bn $3.5bn
Revenue growth, last 12 months −3.5% 17.5% −17.7% −22.0% 4.6% 4.6% 3.7%
Revenue growth, 3-year average −3.6% −4.5% — −17.2% −1.7% — −4.2%
Revenue growth, latest quarter −9.7% 20.0% — −80.5% 1.1% — −1.2%
Gross margin 29.4% 33.5% 34.9% 22.0% 31.8% 30.6% 31.0%
Operating margin −5.2% 28.1% −9.8% −97.0% 11.0% 8.1% 3.4%
Operating margin, 3-year average −7.2% 21.1% 4.6% −29.8% 6.8% 12.4% 6.8%
Net margin −10.7% 23.7% −110.8% −151.2% 2.1% 3.2% 2.1%
Cash from operations / revenue −8.2% 31.3% 27.7% 15.1% 10.6% 14.8% 14.8%
Free-cash-flow margin −9.2% 21.4% 27.3% 13.1% 7.6% 4.6% 7.4%
Free-cash-flow margin, 3-year average −3.7% 19.8% 10.9% 5.8% 14.4% 7.0% 9.1%
Stock pay / revenue 0.3% 1.3% 0.1% 0.9% 1.4% 0.2% 0.6%
Change in share count 1.5% 0.0% 0.7% 1.5% 3.2% 0.1% 0.1%

Median of all 11 companies we cover in fertilizers & agricultural chemicals. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

11 fertilizers & agricultural chemicals companies
Measure Company Peer median Rank
Revenue growth Growth -3.5% 3.7% 8 of 11
Change in growth rate Growth -2.6pp -0.8pp 9 of 11
Gross margin Profitability 29.4% 31.0% 8 of 11
Operating margin Profitability -5.2% 8.1% 7 of 9
Net margin Profitability -10.7% 2.1% 8 of 11
Free-cash-flow margin Cash generation -9.2% 7.4% 10 of 11
Stock pay as % of revenue Cash generation 0.3% 0.6% 3 of 9
Long-term debt as % of assets Balance sheet 41.8% 21.3% 8 of 11
Change in share count Balance sheet 1.5% 0.1% 8 of 11
Days sales outstanding Balance sheet 125 days 75 days 7 of 7

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue YoY
US Crop $221M ▼ 3.0%
US Non Crop $90.3M ▲ 9.6%

These categories overlap or exclude eliminations, so shares aren't shown.

Geography
Region Revenue YoY
United States $312M ▲ 0.3%
International Customers $219M ▼ 8.4%
Outside the US $203M ▼ 14.0%
Central and South America $119M ▲ 0.8%
Mexico $43.2M ▼ 10.8%
Asia $28.4M ▼ 16.8%
Australia $15.7M ▼ 27.5%
Canada $8.8M ▲ 2.9%
Europe $1.8M ▼ 3.6%
Africa $1.4M ▼ 75.8%
Middle East $732,000 ▼ 0.9%

These categories overlap or exclude eliminations, so shares aren't shown.

From American Vanguard Corp's 10-K filed March 16, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$41.2M
Institutions reporting
105
Shares held vs prior quarter
▼ 16.4%
Positions opened / closed
22 / 32

Top buyers and sellers, Q2 2026: 56 institutions bought and 67 sold ; the biggest buyer was Rbf Capital, LLC (+419K shares) and the biggest seller Blackrock, Inc (−1.1M). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Wellington Management Group LLP $4.8M 1.7M 11.7% ▲ 4.1%
Vanguard Capital Management LLC $3.2M 1.1M 7.8% ▲ 0.6%
Blackrock, Inc. $2.6M 933K 6.3% ▼ 55.1%
Evr Research LP $2.2M 775K 5.3% ▲ 7.6%
Dimensional Fund Advisors LP $2.2M 775K 5.3% ▼ 25.9%
Two Sigma Investments, LP $2.1M 733K 5.0% ▼ 1.8%
Cruiser Capital Advisors, LLC $1.6M 572K 3.9% 0.0%
D. E. Shaw & Co., Inc. $1.5M 530K 3.6% 0.0%
Castleknight Management LP $1.4M 504K 3.4% 0.0%
Rbf Capital, LLC $1.2M 419K 2.8% New
Pullen Investment Management, LLC $1.1M 379K 2.6% ▲ 1.3%
AQR Capital Management LLC $1M 373K 2.5% ▲ 122.5%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not American Vanguard Corp's complete shareholder register. Values are as reported by the filers ; 1 inconsistently scaled filing rows were excluded.

Insider trading activity

Full insider history and chart
Insider purchases History → $237,110 5 trades by 3 insiders, last 12 months Insider sales History → $1.2M 1 trade by 1 insider · 0% under pre-set plans
Net ▼ $987,366 net selling
Insider Date Trade Shares Price Value
Cruiser Capital Advisors, Llc 10% owner August 18, 2026 Sell 556,580 $2.20 $1.2M
Macicek Steven D Director August 17, 2026 Buy 19,000 $2.09 $39,710
Kaye Douglas CHIEF EXECUTIVE OFFICER June 3, 2026 Buy 5,000 $2.50 $12,500
Gottschalk Patrick E Director May 19, 2026 Buy 25,000 $2.70 $67,500
Gottschalk Patrick E Director May 13, 2026 Buy 20,000 $2.95 $59,000
Gottschalk Patrick E Director May 12, 2026 Buy 20,000 $2.92 $58,400

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

Next expected around November 18, 2026 estimated from the company's past filing pattern, not announced

  • August 11, 2026
  • March 18, 2026
  • November 12, 2025
  • August 1, 2025
  • June 6, 2025
  • March 14, 2025

Recent SEC filings

Data status

When each part of this page on American Vanguard Corp was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

American Vanguard Corp in brief

What does American Vanguard Corp do?
American Vanguard Corp is a US-listed company in the fertilizers & agricultural chemicals industry. Its financial year ends in December.
What is American Vanguard Corp's stock ticker?
American Vanguard Corp trades under the ticker AVD on NYSE. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is American Vanguard Corp's revenue, and how fast is it growing?
Over its most recent trailing twelve months, American Vanguard Corp reported revenue of $510M, 3.5% lower than a year earlier, according to its SEC filings.
What is American Vanguard Corp's free cash flow?
American Vanguard Corp's free-cash-flow margin is -9.2% of revenue over the trailing twelve months, ranking 10 of the 11 fertilizers & agricultural chemicals companies we cover.
Who are American Vanguard Corp's largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Wellington Management Group LLP, Vanguard Capital Management LLC and Blackrock, Inc. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
What is American Vanguard Corp's market cap?
On November 2, 2026, American Vanguard Corp's market capitalisation was about $31.2M and net debt of $0. Market figures come from third-party market data and may be delayed.
Does American Vanguard Corp pay a dividend?
American Vanguard Corp reported no dividend payments in its trailing twelve months of filings.
How much debt does American Vanguard Corp have?
American Vanguard Corp's debt-to-equity ratio is 147.5%, from its latest balance sheet (14.0% five years earlier). The financial health section below sets out its other solvency checks.
Who are American Vanguard Corp's competitors?
In our Fertilizers & Agricultural Chemicals peer group, the companies closest to American Vanguard Corp are CVR Partners, LP, Bioceres Crop Solutions Corp., FMC Corp, Scotts Miracle-gro Co and ICL Group Ltd. The side-by-side comparison below sets their revenue, margins and growth against American Vanguard Corp's.
Are insiders buying or selling American Vanguard Corp stock?
Over the last 12 months, American Vanguard Corp's directors and officers reported 5 open-market purchases and 1 sales on Form 4. The insider trading page charts every trade.
When is American Vanguard Corp's next earnings date?
Around November 9, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — American Vanguard Corp announces its own schedule.